# University of Utah: Phase 2 study withdrawn (Knee Osteoarthritis, Knee Osteoarthritis (Knee OA))

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | University of Utah |
| Sponsor type | Academic and hospital |
| Study | Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis |
| NCT ID | NCT06859164 |
| Phase | Phase 2 |
| Status | withdrawn |
| Conditions | Knee Osteoarthritis; Knee Osteoarthritis (Knee OA); Knee Osteoarthritis (OA) |
| Intervention types | procedure, device |
| Site countries | United States |
| Posted | 2025-03-05 |
| Planned start | 2025-05-01 |
| Event | Withdrawn before enrolling |
| Event date | 2026-10-27 |
| Last update posted | 2026-10-27 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.
- Phase 2: multi-site, larger budget.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT06859164). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.